Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Chronic Liver Disease”

97 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 97 results

Large-scale testing (Phase 3)Study completedNCT02319031
What this trial is testing

Safety and Efficacy Study of the Combination Daclatasvir (60 mg), Sofosbuvir (400 mg) and Ribavirin (Weight-based Dosing) for 12 or 16 Weeks in Subjects With Genotype 3 Chronic HCV Infection With or Without Prior Treatment Experience and Advanced Fibrosis or Compensated Cirrhosis

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 53
Not applicableLooking for participantsNCT05998330
What this trial is testing

LiverPAL: A Trial of Inpatient Palliative Care for Patients With Advanced Liver Disease

Who this might be right for
Liver Disease ChronicEnd Stage Liver DIseaseCirrhosis+2 more
Massachusetts General Hospital 200
Not applicableLooking for participantsNCT06266260
What this trial is testing

Direct Portal Pressure Measurement Via Endoscopic Ultrasound in Advanced Chronic Liver Disease (EVADIPP)

Who this might be right for
Portal Hypertension
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 50
Post-approval studies (Phase 4)Ended earlyNCT05717400
What this trial is testing

Improving Response to Immunotherapy in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C Virus Infection With Direct-Acting Antiviral Therapy

Who this might be right for
Liver Cancer
M.D. Anderson Cancer Center 2
Post-approval studies (Phase 4)Study completedNCT00347009
What this trial is testing

Adefovir Dipivoxil For The Treatment Of Patients With Chronic Hepatitis B Related Advanced Fibrosis Or Cirrhosis

Who this might be right for
Hepatitis B, ChronicCirrhosisFibrosis+1 more
GlaxoSmithKline 155
Not applicableStudy completedNCT00252642
What this trial is testing

Peginterferon Alpha-2a Maintenance Therapy for Portal Hypertension in Patients With Hepatitis C

Who this might be right for
Hepatitis CCirrhosisFibrosis
Virginia Commonwealth University 60
Early research (Phase 1)Study completedNCT00608361
What this trial is testing

Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery

Who this might be right for
Adult Acute Lymphoblastic Leukemia in RemissionAdult B Acute Lymphoblastic LeukemiaAdult Hepatocellular Carcinoma+82 more
National Cancer Institute (NCI) 80
Not applicableUnknownNCT04421118
What this trial is testing

The Precise Selection of Stent Diameter for Portal Hypertension Patients With TIPS

Who this might be right for
Compensated Advanced Chronic Liver DiseasePortal Hypertension
First Affiliated Hospital of Zhejiang University 60
Large-scale testing (Phase 3)Study completedNCT02115321
What this trial is testing

Study of Efficacy and Safety of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in Chronic Hepatitis C Participants With Child-Pugh (CP)-B Hepatic Insufficiency (MK-5172-059)

Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC 40
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Not applicableStudy completedNCT04455464
What this trial is testing

Effect of Midodrine on HVPG in Advanced Chronic Liver Disease

Who this might be right for
Chronic Liver Disease
Institute of Liver and Biliary Sciences, India 60
Testing effectiveness (Phase 2)UnknownNCT05542615
What this trial is testing

Prolonged Release Pirfenidone for Advanced Residual Liver Fibrosis (MINERVA).

Who this might be right for
Liver CirrhosisHepatitis C, ChronicEpigenetic Disorder
University of Guadalajara 60
Early research (Phase 1)Study completedNCT06973005
What this trial is testing

Investigate How Multiple Oral Doses of AZD2389 Affect the Pharmacokinetics of Midazolam, Caffeine, and Bupropion in Healthy Participants

Who this might be right for
Advanced Chronic Liver DiseaseHealthy Participants
AstraZeneca 16
Not applicableLooking for participantsNCT06523608
What this trial is testing

Prediction of Decompensation and HCC Development in Advanced Chronic Liver Disease

Who this might be right for
Liver DiseasesHepatocellular CarcinomaHepatocarcinoma+1 more
University Hospital Muenster 600
Post-approval studies (Phase 4)Study completedNCT02907749
What this trial is testing

Spironolactone on Fibrosis Progrssion-Portal Hypertension(FP-PH)in Cirrhosis

Who this might be right for
CirrhosisPortal Hypertension
Changqing Yang 96
Early research (Phase 1)Study completedNCT03814005
What this trial is testing

Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver Problems

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myelomonocytic, ChronicLeukemia, Myeloid, Acute+3 more
Takeda 17
Not applicableUnknownNCT06144437
What this trial is testing

Liver and Spleen Stiffness Measured by TE and 2D-SWE for Diagnosis of GOV in Patients With cACLD

Who this might be right for
Liver CirrhosisLiver FibrosisPortal Hypertension
Fifth Affiliated Hospital, Sun Yat-Sen University 150
Not applicableUnknownNCT06147947
What this trial is testing

Liver and Spleen Stiffness Measured by TE and 2D-SWE for Diagnosis of CSPH in Patients With cACLD

Who this might be right for
Liver CirrhosisLiver FibrosisPortal Hypertension
Fifth Affiliated Hospital, Sun Yat-Sen University 150
Not applicableStudy completedNCT05100485
What this trial is testing

Algorithm to Stratify Clinical Decompensation Risk in Patients With Compensated Advanced Chronic Liver Disease (CHESS2108)

Who this might be right for
Compensated Advanced Chronic Liver Disease
Hepatopancreatobiliary Surgery Institute of Gansu Province 1,000
Not applicableUnknownNCT06147934
What this trial is testing

Liver and Spleen Stiffness Measured by 2D-SWE for Diagnosis of Liver Fibrosis in Patients With cACLD

Who this might be right for
Liver FibrosisLiver Cirrhosis
Fifth Affiliated Hospital, Sun Yat-Sen University 150
Load More Results